BPC-157 Is Finally Getting a Placebo-Controlled Trial on Torn Rotator Cuffs
A University of Arkansas trial will test BPC-157 against saline after rotator cuff surgery. It’s small and hasn’t started, and I’m excited anyway.
Medicine 3.0, Peptides
Peptides
Investigations, Peptides
How a Hacked North Carolina Town Website Funneled Google Searches to Peptide Sellers in China
A hacked small-town government website is ranking on Google for real peptide brands and redirecting searchers into a WhatsApp sales operation.
GLP-1
Brenipatide Side Effects: What’s Known and What Isn’t
Updated September 26, 2026 with Lilly’s first Phase 1 safety data and a note that the drug is dosed weekly, not monthly. Brenipatide side effects: thirteen registered trials, ten conditions, and not one has reported. Here is what is actually known. I take tirzepatide every Friday, so I know exactly what a GLP-1 does to
Medicine 3.0, Peptides
BPC-157 Human Trials: 5 Studies, ~80 People, One Failed RCT
Not one of them tested an injury. I pulled every record in FDA’s July 2026 review and the registries behind it.
Medicine 3.0, Preventive Health
FDA-Approved Isn’t a Purity Guarantee. It’s an Accountability Guarantee.
I inject a drug made by a compounding pharmacy with a warning letter to its name. Reading that letter is what taught me how to buy every drug I take.
Healthcare, Preventive Health
Peptides Promise Everything. An FDA Panel Just Said Yes to Six of Seven.
The FDA’s compounding committee voted on seven peptides, recommending BPC-157. What peptides are, why the market exploded, and what the vote does and does not decide.
Healthcare, Medicine 3.0, Preventive Health
I Wanted to Know If BPC-157 Could Help My Aorta. No One Could Tell Me.
BPC-157 promises what an aging body wants most: faster healing, less pain, a return to the version of you that bounced back. It has almost no human evidence behind it. People are sure it works anyway, and in July an FDA committee votes on whether to let pharmacies make it.
Fitness Journey, GLP-1, Medicine 3.0
Retatrutide: What TRIUMPH-1 Just Showed and the Black Market That Got There First
Lilly’s retatrutide just delivered bariatric-equivalent weight loss in Phase 3. The numbers, why the low dose is the real story, and the gray-market reality that got there first.
Peptides, Training
Peptides: Why I’m Curious — and Why I’m Still Skeptical
I’ll start with a confession: peptides fascinate me. I read the studies. I listen to the podcasts. I’ve absolutely had moments where I thought, “Maybe this is the thing that finally makes recovery easier, fat loss faster, or aging less annoying.” I get why guys fall down this rabbit hole. And I’ve experimented. I’ve used
Peptides, Weight loss
Peptides — the new Wonder Drugs?
There is a lot of buzz about peptides like BPC-157, TB-500, MOTS-C and obviously GLP-1 agonists in the health and fitness world. Every influencer seems to have their favorite “stack” of them that promise energy, endurance, fat burning and general injury healing. As Matt Kaberlein explains thinking of “peptides” as one thing is silly the